Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases.
Pereira F, Serrano A, Manzanedo I, Pérez-Viejo E, González-Moreno S, González-Bayón L, Arjona-Sánchez A, Torres J, Ramos I, Barrios ME, Cascales P, Morales R, Boldó E, García-Fadrique A, Arteaga X, Gutierrez-Calvo A, Sánchez-García S, Asensio E, Ramírez CP, Artiles M, Vaqué J, Parra PA, Villarejo P, Muñoz-Casares C, Turienzo E, Calero A, Torrejimeno IJ, Prieto I, Galindo J, Borrego V, Marcello ME, Rihuete C, Carrasco J, Gomez-Quiles L. Pereira F, et al. Among authors: munoz casares c. BMC Cancer. 2022 May 12;22(1):536. doi: 10.1186/s12885-022-09572-7. BMC Cancer. 2022. PMID: 35549912 Free PMC article. Clinical Trial.
Long-term survival with peritoneal mucinous carcinomatosis from intraductal mucinous papillary pancreatic carcinoma treated with complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Arjona-Sanchez A, Muñoz-Casares C, Ortega-Salas R, Casado-Adam A, Sanchez-Hidalgo JM, Rufián-Peña S. Arjona-Sanchez A, et al. Int J Hyperthermia. 2014 Sep;30(6):408-11. doi: 10.3109/02656736.2014.952251. Int J Hyperthermia. 2014. PMID: 25256894 Free article.
Intraperitoneal hyperthermic chemotherapy after cytoreduction in patients with peritoneal metastases from endometrial cancer. The next frontier?
Navarro-Barrios Á, Gil-Martínez J, Ramos-Bernardo I, Barrios P, Muñoz-Casares C, Torres-Melero J, Pereira F, Manzanedo I, Arjona Á, Martínez-Regueira F, Cascales-Campos PA. Navarro-Barrios Á, et al. Surg Oncol. 2020 Jun;33:19-23. doi: 10.1016/j.suronc.2019.12.002. Epub 2019 Dec 31. Surg Oncol. 2020. PMID: 32561085
The Role of Intraperitoneal Intraoperative Chemotherapy with Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis from Ovarian Cancer-Hyperthermia versus Normothermia: A Randomized Controlled Trial.
Casado-Adam A, Rodriguez-Ortiz L, Rufian-Peña S, Muñoz-Casares C, Caro-Cuenca T, Ortega-Salas R, Fernandez-Peralbo MA, Luque-de-Castro MD, Sanchez-Hidalgo JM, Hervas-Martinez C, Romero-Ruiz A, Briceño J, Arjona-Sánchez Á. Casado-Adam A, et al. Among authors: munoz casares c. J Clin Med. 2022 Sep 29;11(19):5785. doi: 10.3390/jcm11195785. J Clin Med. 2022. PMID: 36233653 Free PMC article.
Treatment of Peritoneal Surface Malignancies by Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Spain: Results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP).
Manzanedo I, Pereira F, Cascales-Campos P, Muñoz-Casares C, Asensio E, Torres-Melero J, Prada-Villaverde A, Caravaca-García I, Gutiérrez-Calvo A, Vaqué J, Ortega G, Titos-García A, González-Sánchez L, Pérez-Viejo E, Serrano Á, Martínez-Torres B, Regecop Group. Manzanedo I, et al. Among authors: munoz casares c. J Clin Med. 2023 May 31;12(11):3774. doi: 10.3390/jcm12113774. J Clin Med. 2023. PMID: 37297969 Free PMC article.
The American Society of Peritoneal Surface Malignancies Multi-Institution evaluation of 1,051 advanced ovarian cancer patients undergoing cytoreductive surgery and HIPEC: An introduction of the peritoneal surface disease severity score.
Foster JM, Sleightholm R, Smith L, Ceelen W, Deraco M, Yildirim Y, Levine E, Muñoz-Casares C, Glehen O, Patel A, Esquivel J. Foster JM, et al. J Surg Oncol. 2016 Dec;114(7):779-784. doi: 10.1002/jso.24406. J Surg Oncol. 2016. PMID: 27792292
21 results